SK281947B6 - Použitie farmaceutických preparátov na báze kurkumínu - Google Patents

Použitie farmaceutických preparátov na báze kurkumínu Download PDF

Info

Publication number
SK281947B6
SK281947B6 SK3374-92A SK337492A SK281947B6 SK 281947 B6 SK281947 B6 SK 281947B6 SK 337492 A SK337492 A SK 337492A SK 281947 B6 SK281947 B6 SK 281947B6
Authority
SK
Slovakia
Prior art keywords
curcumin
preparations
curcuma
inflammatory
chronic
Prior art date
Application number
SK3374-92A
Other languages
English (en)
Slovak (sk)
Other versions
SK337492A3 (en
Inventor
H. P. T. Ammon
Hasan Safayhi
Samuel Hwachukwu Okpanyi
Original Assignee
Steigerwald Arzneimittelwerk Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Steigerwald Arzneimittelwerk Gmbh filed Critical Steigerwald Arzneimittelwerk Gmbh
Publication of SK337492A3 publication Critical patent/SK337492A3/sk
Publication of SK281947B6 publication Critical patent/SK281947B6/sk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
SK3374-92A 1991-11-14 1992-11-12 Použitie farmaceutických preparátov na báze kurkumínu SK281947B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4137540A DE4137540A1 (de) 1991-11-14 1991-11-14 Verwendung von praeparaten der curcuma-pflanzen
US07/974,056 US5401777A (en) 1991-11-14 1992-11-10 Use of preparations of curcuma plants

Publications (2)

Publication Number Publication Date
SK337492A3 SK337492A3 (en) 1995-05-10
SK281947B6 true SK281947B6 (sk) 2001-09-11

Family

ID=25909167

Family Applications (1)

Application Number Title Priority Date Filing Date
SK3374-92A SK281947B6 (sk) 1991-11-14 1992-11-12 Použitie farmaceutických preparátov na báze kurkumínu

Country Status (12)

Country Link
US (1) US5401777A (fr)
EP (2) EP0550807A3 (fr)
JP (1) JPH05262659A (fr)
CA (1) CA2082562A1 (fr)
CZ (1) CZ288163B6 (fr)
DE (1) DE4137540A1 (fr)
EG (1) EG20056A (fr)
HU (1) HUT62801A (fr)
PL (1) PL296570A1 (fr)
RU (1) RU2121832C1 (fr)
SK (1) SK281947B6 (fr)
ZA (1) ZA928554B (fr)

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925376C1 (en) * 1994-01-10 2001-03-20 Madalene C Y Heng Method for treating psoriasis using selected phosphorylase kinase inhibitor and additional compounds
JP3048642B2 (ja) * 1994-08-03 2000-06-05 エイ・エス・エイ・シー・ファーマシューティカル・インターナショナル,エイ・アイ・イー ウコンの無極性および極性抽出物の取得方法およびその用途
ES2081264B1 (es) * 1994-08-03 1996-08-16 A C Pharmaceutical Internation Procedimiento para la obtencion de extractos apolares y polares de curcuma y aplicaciones de los mismos.
ATE227572T1 (de) * 1995-07-14 2002-11-15 Sabinsa Corp Lebenschützende mittel, verfahren zu deren verwendung sowie extraktionsverfahren für curcuminoide
ZA967730B (en) * 1995-09-14 1998-03-13 Res Dev Foundation Curcumin (diferuloylmethane) inhibition of NFκB Activation.
US5861415A (en) * 1996-07-12 1999-01-19 Sami Chemicals & Extracts, Ltd. Bioprotectant composition, method of use and extraction process of curcuminoids
GB9711962D0 (en) * 1997-06-10 1997-08-06 Reckitt & Colmann Prod Ltd Therapeutically active compositions
JP2002500209A (ja) 1998-01-09 2002-01-08 アイダ ディベロップメント アクティーゼルスカブ 或る種のジテルペン類そして医薬品として使用するためにこれらを含有するCurcumaamadaの抽出物及び濃縮物
US6210701B1 (en) * 1999-04-30 2001-04-03 Healthcomm International, Inc. Medical food for treating inflammation-related diseases
US20010051184A1 (en) * 1999-05-20 2001-12-13 Madalene C.Y. Heng Method for using soluble curcumin to inhibit phosphorylase kinase in inflammatory diseases
US6673843B2 (en) * 1999-06-30 2004-01-06 Emory University Curcumin and curcuminoid inhibition of angiogenesis
ES2154610B1 (es) * 1999-09-23 2001-11-16 Asac Compania De Biotecnologia Nuevas actividades farmacologicas de los extractos de curcuma longa.
US20040266883A1 (en) * 1999-10-27 2004-12-30 Yale University Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
US20030149113A1 (en) * 2001-10-12 2003-08-07 Caplan Michael J. Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
US20030236300A1 (en) * 1999-10-27 2003-12-25 Yale University Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
US8076312B2 (en) * 2000-01-10 2011-12-13 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Use of lipid conjugates in the treatment of disease
US7811999B2 (en) * 2000-01-10 2010-10-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Use of lipid conjugates in the treatment of diseases
US9040078B2 (en) * 2000-01-10 2015-05-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of diseases of the nervous system
US7893226B2 (en) * 2004-09-29 2011-02-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Use of lipid conjugates in the treatment of diseases
US8304395B2 (en) * 2000-01-10 2012-11-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Lipid conjugates in the treatment of disease
US20090325876A1 (en) * 2004-09-29 2009-12-31 Saul Yedgar Use of lipid conjugates in the treatment of diseases associated with vasculature
US8916539B2 (en) * 2000-01-10 2014-12-23 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of disease
US7608598B2 (en) 2000-01-10 2009-10-27 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of conjunctivitis
US7772196B2 (en) * 2000-01-10 2010-08-10 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of diseases
US8501701B2 (en) * 2000-01-10 2013-08-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Use of lipid conjugates in the treatment of disease
WO2001095727A1 (fr) * 2000-06-13 2001-12-20 Wyeth Formule phyto-alimentaire permettant de soulager les douleurs chroniques d'origine inflammatoire
US6492429B1 (en) 2000-07-10 2002-12-10 N.V. Nutricia Composition for the treatment of osteoarthritis
US8883761B2 (en) * 2001-01-10 2014-11-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of diseases associated with vasculature
KR20020073847A (ko) * 2001-03-16 2002-09-28 주식회사 바이오시너젠 쿠르쿠민 또는 울금 추출물을 포함하는 치매 예방 및치료용 조성물
US6387416B1 (en) * 2001-04-05 2002-05-14 Thomas Newmark Anti-Inflammatory herbal composition and method of use
US20040037903A1 (en) * 2001-06-13 2004-02-26 Lemmo Edward A. Phytonutrient formula for the relief of chronic pain resulting from inflammation
US6596313B2 (en) * 2001-08-06 2003-07-22 The Quigley Corporation Nutritional supplement and methods of using it
JP5384777B2 (ja) * 2001-12-18 2014-01-08 有限会社大長企画 強筋肉剤、抗炎症剤
JP2012149096A (ja) * 2001-12-18 2012-08-09 Daicho Kikaku:Kk 抗炎症剤
US20090011991A1 (en) * 2002-03-08 2009-01-08 Emory University Novel Curcuminoid-Factor VIIA Constructs as Suppressors of Tumor Growth and Angiogenesis
US20060229239A9 (en) * 2002-03-08 2006-10-12 Mamoru Shoji Novel curcuminoid-factor VIIa constructs as suppressors of tumor growth and angiogenesis
KR20030074017A (ko) * 2002-03-15 2003-09-19 한국생명공학연구원 쿨쿠민 및 그 유도체의 제조방법 및 이를 유효성분으로함유하는 암의 예방 및 치료용 약학적 조성물
US6811796B2 (en) * 2002-04-22 2004-11-02 Matsuura Yakugyo Co., Ltd. Preventive or therapeutic agent for pollen allergy, allergic rhinitis, atopic dermatitis, asthma or urticaria, or health food for prevention or improvement or reduction of symptoms thereof
WO2003090681A2 (fr) * 2002-04-24 2003-11-06 Research Development Foundation Effets synergetiques des inhibiteurs du facteur nf-kb de transcription nucleaire et d'agents anti-cancereux
AU2003253681B2 (en) * 2002-06-24 2008-05-01 Research Development Foundation Treatment of human multiple myeloma by Curcumin
US7060733B2 (en) * 2002-08-15 2006-06-13 The Regents Of The University Of California Methods for treating pancreatitis with curcumin compounds and inhibitors of reactive oxygen species
US20040259816A1 (en) * 2002-10-01 2004-12-23 Pandol Stephen J. Compositions comprising plant-derived polyphenolic compounds and inhibitors of reactive oxygen species and methods of using thereof
EP1638541B1 (fr) * 2003-06-27 2010-05-19 Astellas Pharma Inc. Agent therapeutique contre le sarcome des tissus mous
CA2536738A1 (fr) * 2003-08-26 2005-03-10 Research Development Foundation Administration par aerosol de curcumine
AU2004320907A1 (en) 2003-08-26 2006-04-13 Research Development Foundation Osteoclastogenesis inhibitors and uses thereof
US20050244522A1 (en) * 2004-04-30 2005-11-03 Carrara Dario Norberto R Permeation enhancer comprising genus Curcuma or germacrone for transdermal and topical administration of active agents
WO2005113069A2 (fr) * 2004-05-14 2005-12-01 Research Development Foundation Utilisation de curcumine et d'analogues de curcumine comme inhibiteurs de l'acc2
WO2006020246A1 (fr) * 2004-07-23 2006-02-23 Tsung-Chung Lin Inflammation anti-hypersensible et activités anti-allergiques du zingiber zerumbet (l.) smith
US7514092B2 (en) * 2004-12-22 2009-04-07 Avon Products, Inc. Compositions and methods of their use for improving the condition and appearance of skin
US20060275516A1 (en) * 2005-06-02 2006-12-07 Ram A N S Compositions and methods for the treatment of allergic rhinitis
JP5032003B2 (ja) * 2005-06-15 2012-09-26 株式会社琉球バイオリソース開発 口腔粘膜用の鎮痛・抗炎症トローチ剤
CA2611489A1 (fr) * 2005-06-15 2006-12-28 Darrick S.H.L. Kim Preparations pharmaceutiques synergiques pouvant etre employees dans le traitement prophylactique et therapeutique d'une maladie induite par la proteine beta-amyloide, incluant des composes derives de la sauge et du romarin
CA2617484A1 (fr) * 2005-08-03 2007-02-15 Morria Biopharmaceuticals Utilisation de conjugues lipides en cas de fibrose cystique et applications correspondantes
WO2007046113A2 (fr) * 2005-10-18 2007-04-26 Panacea Biotec Ltd. Composition pharmaceutique renfermant un ou plusieurs alcaloides et procede
US8859524B2 (en) 2005-11-17 2014-10-14 Yissum Research Development Company Of The Hebrew University Of Jerusalem Lipid conjugates in the treatment of chronic rhinosinusitis
US8906882B2 (en) 2005-11-17 2014-12-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Lipid conjugates in the treatment of allergic rhinitis
US20070160696A1 (en) * 2006-01-11 2007-07-12 The Procter & Gamble Company Compositions and methods useful for prevention or treatment of respiratory illness
US20080075671A1 (en) * 2006-09-22 2008-03-27 Di Mauro Thomas M Intranasally administering curcumin to the brain to treat alzheimer's disease
US20090087385A1 (en) * 2006-09-22 2009-04-02 Di Mauro Thomas M Intranasally administering curcumin in a bolus of helium gas to treat alzheimers disease
CA2705785A1 (fr) * 2006-11-14 2008-05-22 Saul Yedgar Utilisation de conjugues lipidiques dans le traitement de maladies ou de troubles oculaires
US8383865B2 (en) * 2007-04-17 2013-02-26 Codman & Shurtleff, Inc. Curcumin derivatives
JP2010524959A (ja) * 2007-04-17 2010-07-22 コドマン・アンド・シャートレフ・インコーポレイテッド アルツハイマー病を処置するためのヘリウムガスボーラス中のクルクミンの鼻腔投与
DE102007047237B4 (de) * 2007-10-02 2011-07-14 Busch, Klaus-Uwe, Dr. Stoffzusammensetzung und deren Verwendung als Mundhygieneprodukt und Nahrungsergänzungsmittel
WO2009043176A1 (fr) * 2007-10-03 2009-04-09 Sabell Corporation Composition destinée à traiter l'hépatite contenant un extrait de fleurs de cordia lutea, de feuilles d'annona muricata et de racines de curcuma longa
ITMI20072315A1 (it) * 2007-12-11 2009-06-12 Bios Line Spa Composizioni orali per la prevenzione e il trattamento dei disturbi del colon su base infiammatoria
WO2009080850A1 (fr) 2007-12-21 2009-07-02 Asac Compañia De Biotecnologia E Investigacion, S.A. Méthode pour augmenter l'efficacité thérapeutique des curcuminoïdes et analogues
US7745670B2 (en) * 2008-06-27 2010-06-29 Codman & Shurtleff, Inc. Curcumin-Resveratrol hybrid molecule
JP5758563B2 (ja) * 2008-03-28 2015-08-05 丸善製薬株式会社 ヒアルロニダーゼ活性阻害剤、及び腫瘍壊死因子産生抑制剤
US7985776B2 (en) * 2008-06-27 2011-07-26 Codman & Shurtleff, Inc. Iontophoretic delivery of curcumin and curcumin analogs for the treatment of Alzheimer's Disease
CN102215856B (zh) * 2008-12-01 2014-03-05 莱拉制药用品私营有限责任公司 用于炎症、皮肤病、粘膜病以及其它相关疾病治疗的外用制剂
US20100150865A1 (en) * 2008-12-11 2010-06-17 Deepa Chitre Novel formulations to inhibit cyclooxygenase and pro-inflammatory cytokine mediated diseases
US20100286585A1 (en) * 2009-01-26 2010-11-11 Codman & Shurtleff, Inc. Shunt Delivery of Curcumin
US7723515B1 (en) * 2009-01-26 2010-05-25 Codman & Shurtleff, Inc. Methylene blue—curcumin analog for the treatment of alzheimer's disease
EP2410999A4 (fr) * 2009-03-23 2012-04-18 Laila Pharmaceuticals Pvt Ltd Curcuminoïdes et leurs métabolites pour application à des états oculaires/nasaux allergiques
EP2429532A4 (fr) 2009-05-11 2015-05-27 Yissum Res Dev Co Conjugués lipides/polymères, leur préparation et leurs utilisations
EP2672828B1 (fr) * 2011-02-10 2015-04-29 Unilever N.V. Composition antimicrobienne
KR101416149B1 (ko) * 2011-04-20 2014-07-09 한국생명공학연구원 Il-6 유도 stat3 활성화 저해 효과를 갖는 강황 또는 울금의 지상부 추출물, 또는 이의 비극성 유기용매 분획물을 포함하는 조성물
ITMI20111259A1 (it) * 2011-07-06 2013-01-07 Eye Tech Srl Composizione orosolubile a rapida disgregazione contenente derivati di curcumina
RU2508118C1 (ru) * 2012-06-27 2014-02-27 Федеральное государственное казенное военное образовательное учреждение высшего профессионального образования "Военная академия радиационной, химической и биологической защиты имени Маршала Советского Союза С.К. Тимошенко (г. Кострома)" Министерства обороны Российской Федерации Способ повышения радиационной устойчивости организма мышей
US10213382B2 (en) 2014-02-03 2019-02-26 Apurano Pharmaceuticals Gmbh Nanosuspension of natural materials and preparation method thereof
AU2015248504B2 (en) * 2014-04-18 2020-07-09 Omniactive Health Technologies Limited Curcumin compositions and uses thereof
CN104189725A (zh) * 2014-07-24 2014-12-10 汪升静 一种治疗小儿哮喘的中药组合物
JP2015006444A (ja) * 2014-09-19 2015-01-15 スミス・アンド・ネフュー・オルソペディクス・アーゲー 良好な身体応答を示す磨耗粒子を生じる医療用インプラント
US20200360300A1 (en) * 2014-12-31 2020-11-19 Signpath Pharma, Inc. Suppression of Cytokine Release and Cytokine Storm
DE102015008823A1 (de) * 2015-07-15 2017-01-19 Hans Muerth Verwendung des Verfahrens und der Vorichtungen zum Verdampfen von Curcumin-Pulver mit einem Hochleistungs-Verdampfer zwecks Erzeugen eines inhalierbaren Curcumin-Aerosols
RU2743427C1 (ru) * 2020-02-26 2021-02-18 Федеральное государственное бюджетное образовательное учреждение высшего образования "Южно-Уральский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО ЮУГМУ Минздрава России) Ректальные суппозитории, обладающие противовоспалительным, антиоксидантным, иммуностимулирующим действием, содержащие экстракт корневищ с корнями куркумы длинной

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07110828B2 (ja) * 1987-07-30 1995-11-29 株式会社ヤクルト本社 ジフエニルヘプテノン誘導体及びこれを含有する肝障害治療剤
US5120538A (en) * 1990-02-05 1992-06-09 Pt Darya-Varia Laboratoria Combinations of compounds isolated from curcuma spp as anti-inflammatory agents

Also Published As

Publication number Publication date
EP1174130A2 (fr) 2002-01-23
US5401777A (en) 1995-03-28
HUT62801A (en) 1993-06-28
CZ288163B6 (en) 2001-05-16
ZA928554B (en) 1993-05-05
EP0550807A3 (en) 1993-08-25
EG20056A (en) 1997-03-27
RU2121832C1 (ru) 1998-11-20
CZ337492A3 (en) 1993-12-15
HU9203547D0 (en) 1993-01-28
JPH05262659A (ja) 1993-10-12
SK337492A3 (en) 1995-05-10
PL296570A1 (en) 1993-11-02
DE4137540A1 (de) 1993-05-19
EP0550807A2 (fr) 1993-07-14
CA2082562A1 (fr) 1993-05-15

Similar Documents

Publication Publication Date Title
SK281947B6 (sk) Použitie farmaceutických preparátov na báze kurkumínu
AP230A (en) 3-(2-(dimethylamino) ethyl) -n-methyl 1h-indole-5-methane sulphonamide sulphate and pharmaceutical compositions thereof.
US6017932A (en) Pharmaceutical compositions containing at least one NSAID having increased bioavailability
US4322411A (en) Anti-inflammatory nucleosides
EP0914124A1 (fr) COMPOSITION PHARMACEUTIQUE ANTITHROMBOTIQUE ET ANTIATHEROGENE COMPRENANT UN DERIVE DE THIENOPYRIDINE ET UN INHIBITEUR DE LA HMG-CoA-REDUCTASE
NO883146L (no) Antiinflamatorisk aktive arylderivater og fremgangsmaate for deres fremstilling.
CZ288071B6 (cs) Léčivo proti Alzheimerově chorobě
CA2321369C (fr) Dosage du lasofoxifene dans le cadre de regimes
CA2125822A1 (fr) Agent therapeutique contre la maladie d'alzheimer
US5919821A (en) Use of boswellic acid for treating brain tumors
US4331687A (en) Treatment of Parkinson's disease
US6048540A (en) Acetamenophen composition with reduced liver toxicity
NO166569B (no) Fremgangsmaate til fremstilling av farmasoeytisk preparat inneholdende fosfolipider og ikke-steroidale antiflogistika.
US4397858A (en) Treatment of rheumatism and arteriosclerosis with n-halogenophenyl-benzisothiazoles
CA1307739C (fr) Compositions anti-inflammatoires
KR100290512B1 (ko) 항염증 효과를 갖는 심황속 식물 제제
JPS5855423A (ja) ベンゾグアナミン類を主成分としする医薬
US3462534A (en) Production of an antidepressant effect with esters of gallic acid
EA009214B1 (ru) Фармацевтическая композиция, набор и способ лечения вич-инфекций
KR950011409B1 (ko) 히드록시인돌 유도체
IE54257B1 (en) Trans-dihydrolisuride antipsychotic
US4156003A (en) Treatment of hypertension with combination of clofibrinic acid or clofibrate with cinnarizine
JPH0426676A (ja) 新規ジテルペンアルカロイド及びジテルペンアルカロイド類を有効成分とする心疾患治療薬
JPS63267727A (ja) S−ラクトイルグルタチオンおよび/またはその塩を有効成分とする医薬
US3821381A (en) Method of treatment